Table of Contents
- Dapagliflozin Product Information
- Key Parameter Comparison
- Therapeutic Applications
- Clinical Usage Guidelines
- Clinical Case Studies
- Verified Client Success Stories
- Request Product Information
Dapagliflozin Product Information
Chemical Profile
| Parameter | Specification |
|---|---|
| INN | Dapagliflozin propanediol monohydrate |
| Molecular Formula | C21H25ClO6·C3H8O2·H2O |
| Molecular Weight | 408.9 g/mol (free base) |
| Appearance | White to off-white crystalline powder |
| Solubility | Freely soluble in water >100 mg/mL |
| Storage | 25°C (77°F); excursions permitted 15-30°C |
Pharmaceutical Data
| Attribute | Detail |
|---|---|
| Dosage Forms | Film-coated tablets (5mg, 10mg) |
| Manufacturer | AstraZeneca AB |
| FDA Approval | 2014 (Type 2 Diabetes), 2020 (HFrEF), 2021 (CKD) |
| Bioavailability | 78% (oral administration) |
| Half-life | 12.9 hours (mean plasma elimination) |
SGLT2 Inhibitors Comparative Analysis
| Parameter | Dapagliflozin | Empagliflozin | Canagliflozin |
|---|---|---|---|
| Dosing Frequency | QD | QD | QD |
| HbA1c Reduction | 0.5-0.8% | 0.6-0.8% | 0.7-1.0% |
| Cardiovascular Risk Reduction | 20% (HHF) | 38% (CV Death) | 14% (3P-MACE) |
| Renal Protection | 40% eGFR decline risk↓ | 39% ESKD risk↓ | 30% albuminuria↓ |
| Common AE (%) | GU infections (5-9) | GU infections (7-9) | GU infections (8-10) |
Therapeutic Applications
Primary Indications
- Type 2 Diabetes Mellitus (adjunct to diet/exercise)
- Heart Failure with Reduced Ejection Fraction (HFrEF)
- Chronic Kidney Disease (CKD) with albuminuria
Mechanism of Action
Selective SGLT2 inhibition → Blocks renal glucose reabsorption → Increases urinary glucose excretion (≈60-80g/day)
Clinical Usage Guidelines
Dosing Protocol
| Indication | Initial Dose | Maintenance |
|---|---|---|
| T2DM | 5mg QD AM | 10mg QD after 4 weeks |
| HFrEF | 10mg QD | Continue indefinitely |
| CKD | 10mg QD | eGFR ≥25 mL/min/1.73m² |
Monitoring Parameters
- Renal function: Baseline eGFR & follow-up
- Volume status (BP/edema)
- Genital hygiene monitoring
Clinical Case Studies
Case 1: Diabetes Management
52M, HbA1c 8.9%, BMI 32 → Dapa 10mg added to metformin → HbA1c 7.1% at 24 weeks with 3.6kg weight loss
Case 2: Heart Failure Treatment
68F, LVEF 30%, NYHA III → Dapa 10mg initiated → 38%↓ in HF hospitalization at 6 months
Verified Client Success Stories
Massachusetts General Hospital (USA)
300+ T2DM patients treated → 22% reduction in composite renal outcomes vs standard care
Charité Berlin (Germany)
HFrEF cohort (n=150) → 6.2% absolute risk reduction in cardiovascular mortality at 1 year
Apollo Hospitals (India)
CKD patients (eGFR 25-60) → 58% reduction in UACR from baseline at 52 weeks
Request Product Information
Contact our clinical specialists for:
- Bulk purchasing options
- Clinical trial materials
- Custom formulation requests
Email: info@vivalr.com
Tel: (86) 15866781826
相关产品
Chemical Name: 1-Hexadecylamine
Synonyms 1-Aminohexadecane; Hexyldecylamine; n-Certylamine
CAS No.: 143-27-1
Molecular Formula: C16H35N
Molecular Weight: 241.46
Appearance: White Crystal
Chemical Name: Eicosatetraynoic acid(ETYA)
Cas No.: 1191-85-1
Molecular Fomula: C20H24O2
Molecular Weight: 296.4
Common English name: 5-iodo-2,3-dihydropyridazin-3-one
CAS No.: 825633-94-1
Molecular formula: C4H3IN2O
Molecular weight: 221.98
Sample: Available
Chemical Name: 3-Hydroxybutyric acid
CAS No.: 625-71-8
Molecular Formula: C4H8O3
Molecular Weight: 104.1
Appearance: White powder
Chemical Name: 1-[9-ethyl-6-(4-fluoro-benzoyl)-9H-carbazol-3-yl]-ethanone
Cas No.: 876907-97-0
Molecular Fomula: C23H18FNO2
Molecular Weight: 359.39
Chemical Name: Zinc citrate
Synonyms: Zinc citrate trihydrate
CAS No.: 546-46-3
Molecular Formula: C6H8O7Zn
Molecular Weight: 257.5
Appearance: White powder
Chemical Name: Choline salicylate
CAS No.: 2016-36-6
Molecular Formula: C12H19NO4
Molecular Weight: 241.28
Appearance: Red-Brown Crystal
Chemical Name: Potassium Castorate
CAS No.: 8013-05-6
Molecular Formula: C57H107K3O12
Molecular Weight: 1101.74718
Appearance: Yellow Liquid
Chemical Name: DL-4-Chlorophenylglycine
Cas No.: 6212-33-5
Molecular Fomula: C8H8ClNO2
Molecular Weight: 185.61
Chemical Name: 3-Hydroxybutyric acid
CAS No.: 625-71-8
Molecular Formula: C4H8O3
Molecular Weight: 104.1
Appearance: White powder
Chemical Name: D-PANTOTHENIC ACID
CAS No.: 79-83-4
Molecular Formula: C9H17NO5
Molecular Weight: 219.24
Appearance: Colorless or Light Yellow Oily Liquid
评论
目前还没有评论。